CRH plc research snapshot
CRH AI stock analysis reads CRH plc as a high-quality building materials and infrastructure compounder whose record Q2 2026 results, reaffirmed 2026 guidance, and $8.5 billion Arcosa acquisition agreement stand in contrast to a stock price near its 52-week low. At the August 2, 2026 data cutoff, CRH closed at $95.01 on July 31, 2026 with an implied market capitalization of about $63.21 billion. Q2 2026 revenue rose 6% to $10.8 billion, net income rose 13% to $1.5 billion, adjusted EBITDA rose 7% to $2.6 billion, and diluted EPS rose 14% to $2.21, while analysts still hold a Strong Buy consensus with an average target of $140.29. The tension is that the stock trades below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, with a 14-day RSI near 34, so the CRH AI stock forecast is a scenario framework rather than a certain prediction.
Current price
$95.01
Market cap
$63.21 billion
AI score
66 / 100
Rating
High-quality infrastructure compounder with record Q2 2026 results, a Strong Buy consensus, but price near the 52-week low with bearish short-term momentum
Trend status
Bearish short-term momentum with price below every key moving average and near the 52-week low
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | CRH sells aggregates, cementitious materials, asphalt, ready-mixed concrete, paving services, infrastructure products, and outdoor living products that customers need for roads, water, energy, data center, commercial, residential, and reindustrialization projects. | High |
| Moat | The moat comes from local quarry reserves, permitted assets, logistics density, scale purchasing, route proximity, public project relationships, and a connected portfolio across materials, products, and services, reinforced by about 380 million tons of annual aggregates production. | Medium-high |
| Management | Jim Mintern, CEO since January 2025, is running a record quarter with 6% revenue and 7% adjusted EBITDA growth, three divestitures for $1.9 billion, 17 value-accretive acquisitions, and a $8.5 billion agreement to acquire Arcosa that strengthens U.S. aggregates leadership. | Medium-high |
| Financial trend | Q2 2026 total revenue rose 6% to $10.8 billion, net income rose 13% to $1.5 billion, adjusted EBITDA rose 7% to $2.6 billion, and diluted EPS rose 14% to $2.21, with management reaffirming 2026 guidance for net income of $3.9 billion to $4.1 billion. | High |
| Valuation | At $95.01, CRH trades near 16.8x trailing earnings, 15.4x forward earnings, 2.6x book value, 22.8x free cash flow, and 1.6x sales, which is a moderate multiple for the quality and growth profile. | Medium-high |
| Technical trend | CRH closed near $95.01 on July 31, 2026, below the 5-day $99.40, 20-day $101.98, 50-day $104.88, 100-day $107.23, and 200-day $113.98 moving averages, with a 14-day RSI near 34 and a negative directional index gap that favors sellers. | Medium |
| Risk level | Key risks are the Arcosa transaction closing and integration, a paused buyback, higher debt and interest expense, construction cyclicality, weather, infrastructure funding timing, haulage and input cost inflation, and valuation compression. | Medium-high |
| AI confidence | Descriptive confidence is high because official filings and third-party data align closely. Return confidence is lower because CRH is exposed to the Arcosa deal, macro demand, rates, and investor multiples. | High data confidence |
| Investment certainty | CRH looks like a strong operator with record results and a credible growth plan, but the price action is weak and the acquisition adds execution risk, so certainty is medium rather than high. | Medium |
CRH AI stock forecast
The CRH AI stock forecast uses scenario math around the July 31, 2026 close of $95.01 and the FY2026 adjusted EPS consensus near $5.92. The audited three-year model produced a bullish area near $145.70, a base area near $123.30, and a bearish area near $77.60 before dividends. These are scenario anchors, not exact predictions.
$135 to $158
More likely if infrastructure demand and reindustrialization activity stay strong, data center projects convert into volumes, the Arcosa deal closes in Q1 2027 and delivers its $175 million of year-three synergies, adjusted EBITDA margin keeps expanding, and investors value CRH near a low-20s earnings multiple.
$112 to $132
More likely if revenue grows at a mid-single-digit to high-single-digit pace, adjusted EPS compounds near 7%, Arcosa closes on schedule without major disruption, and the market holds CRH near a mid-teens multiple.
$70 to $85
More likely if construction volumes weaken, infrastructure funding is delayed, Arcosa integration disappoints or the deal faces problems, net debt keeps rising while the buyback stays paused, margins roll over, or the market re-rates CRH toward a low-teens earnings multiple.
CRH AI technical analysis
CRH AI technical analysis is bearish as of the August 2, 2026 data cutoff. The stock closed near $95.01 on July 31, 2026, below the 5-day $99.40, 20-day $101.98, 50-day $104.88, 100-day $107.23, and 200-day $113.98 moving averages. StockAnalysis reported a 14-day RSI near 34.40, and Barchart showed a 14-day ADX near 23.59 with -DI near 34.32 well above +DI near 14.48, a bearish momentum profile near the 52-week low of $93.58.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $95.01 | StockAnalysis real-time quote at the July 31, 2026 close; market cap math uses 665.28 million shares outstanding. |
| Immediate support | $93.58 | The 52-week low of $93.58 is the immediate downside reference; a close below it would extend the downtrend. |
| Near support zone | $93 to $97 | The current price is trading right at the low end of the recent range, so the $93.58 low plus round numbers near $95 to $97 form the first support cluster. |
| Near resistance | $99 to $102 | The 5-day moving average near $99.40 and the 20-day moving average near $101.98 create the first upside test. |
| Next resistance | $104 to $108 | The 50-day moving average near $104.88 and the 100-day moving average near $107.23 form the next resistance band. |
| 200-day moving average | $113.98 | StockAnalysis lists the 200-day trend line near $113.98, well above the current price, which keeps the longer-term trend under pressure. |
| Momentum | RSI near 34, ADX favors sellers | StockAnalysis reports a 14-day RSI near 34.40, approaching oversold, and Barchart shows -DI near 34.32 above +DI near 14.48 with ADX near 23.59, meaning sellers dominate. |
| Volume | About 3.8 to 4.0 million average shares | StockAnalysis lists 20-day average volume near 3.80 million and Barchart near 3.98 million shares, useful for checking whether any rebound attempt has volume support. |
| Volatility | Elevated, beta near 1.21 | Barchart reports 14-day historical volatility near 32.7% and StockAnalysis lists beta near 1.21, so position sizing should allow for wider swings than the broad market. |
| Invalidation | Close below $93.58, then stabilization above $105 | A decisive close below the $93.58 52-week low would confirm more downside. A sustained move back above the 50-day near $104.88 to $105 would be the first sign of a trend stabilization. |
CRH AI trading strategy
The CRH AI trading strategy below is a rules-based research framework, not personal financial advice. It combines Arcosa deal progress, infrastructure demand checks, margin and debt discipline, valuation ranges, and technical invalidation levels.
Watch for CRH to reclaim the $99 to $102 resistance zone and then the $104 to $108 band while Q3 data confirms 2026 guidance, Arcosa integration advances toward a Q1 2027 close, and adjusted EBITDA margin holds.
A failed reclaim followed by a close below the $93.58 52-week low should reduce setup confidence because price would confirm a bearish trend below every moving average.
With the 14-day RSI near 34 and price near the 52-week low, CRH is closer to an oversold condition, but wait for a stabilization pattern or a close back above the 20-day moving average near $102 rather than catching a falling knife.
Do not treat the low price as attractive if the Arcosa deal faces delays, net debt keeps rising while buybacks stay paused, organic volume weakens, or management cuts 2026 guidance.
Track Q2 momentum carryover, adjusted EBITDA margin, Arcosa close and synergy delivery, net debt, free cash flow conversion, buyback restart timing, acquisition spend, dividends, organic volume and price, and public infrastructure funding.
Position sizing should reflect that CRH is a cyclical materials company that is also executing a large acquisition, so capital allocation risk rises while the buyback is paused.
Investment research summary
Customers pay CRH because roads, water systems, data centers, energy projects, and buildings need local materials, permitted reserves, logistics, engineering know-how, and reliable delivery. The business turns hard-to-replicate local assets into recurring infrastructure and construction demand.
CRH benefits from quarry reserves, permits, route density, local market share, vertical integration, public project relationships, and scale, reinforced by about 380 million tons of annual aggregates production and the pending Arcosa addition.
The thesis fails if the Arcosa deal closes late, overpays, or integrates poorly, if the buyback stays paused while debt rises, if public infrastructure demand slows, if weather disrupts volumes, if pricing weakens, or if investors stop paying a premium for a cyclical materials compounder.
Management delivered a record Q2 2026 with 6% revenue and 7% adjusted EBITDA growth, completed three divestitures for $1.9 billion, and agreed the $8.5 billion Arcosa acquisition. The key test for Jim Mintern is whether CRH can execute the integration and resume returns without breaking the balance sheet.
CRH sits in long-term demand for infrastructure modernization, road repair, water systems, reindustrialization, energy projects, and data center construction. The offset is that construction activity is tied to rates, budgets, weather, and local economic cycles, and new build residential stays subdued.
At roughly 16.8x trailing earnings, 15.4x forward earnings, and 22.8x free cash flow, CRH is not distressed. Margin of safety depends on Arcosa execution, sustained EBITDA growth, debt discipline, and evidence that infrastructure demand offsets cyclical weakness.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CRH quote reference | $95.01 at the July 31, 2026 close, after-hours near $95.48 | StockAnalysis CRH overview page | July 31, 2026 |
| Market capitalization verification | $63.21 billion calculated from $95.01 x 665.28 million shares with 0.00% deviation, matching StockAnalysis reported market cap | Pineify financial_rigor.py and StockAnalysis CRH statistics | August 2, 2026 |
| Shares outstanding | 665.28 million shares outstanding, 664.25 million float, insiders near 0.13%, institutions near 87.80% | StockAnalysis CRH statistics | August 2, 2026 |
| Q2 2026 headline results | $10.8 billion total revenue up 6%, $1.5 billion net income up 13%, $2.6 billion adjusted EBITDA up 7%, $2.21 diluted EPS up 14% | CRH Q2 2026 results announcement | July 30, 2026 |
| Q2 2026 margins | Net income margin 14.0% up 90bps, adjusted EBITDA margin 24.4% up 30bps | CRH Q2 2026 results announcement | July 30, 2026 |
| Q2 2026 segment results | Americas Materials revenue up 10% and adjusted EBITDA up 12%; Americas Building revenue down 2% and adjusted EBITDA down 8%; International revenue up 5% and adjusted EBITDA up 8% | CRH Q2 2026 results announcement appendix | July 30, 2026 |
| Q2 2026 Americas Materials detail | Aggregates volume up 2% and price up 5%, cement volume down 2% and price down 1%, asphalt volume up 3% and price up 6% | CRH Q2 2026 results announcement appendix | July 30, 2026 |
| H1 2026 results | $18.147 billion total revenue, $1.331 billion net income, $3.213 billion adjusted EBITDA, $1.93 diluted EPS | CRH Q2 2026 results announcement condensed income statement | July 30, 2026 |
| FY2026 guidance | Reaffirmed net income of $3.9 billion to $4.1 billion, adjusted EBITDA of $8.1 billion to $8.5 billion, diluted EPS of $5.60 to $6.05, and capital expenditure of $2.7 billion to $2.9 billion | CRH Q2 2026 results announcement | July 30, 2026 |
| Balance sheet, June 30, 2026 | $3.025 billion cash, $17.926 billion total debt, and $15.416 billion net debt per the company net debt reconciliation | CRH Q2 2026 results announcement balance sheet and net debt reconciliation | July 30, 2026 |
| H1 2026 cash flow | Operating cash flow of $513 million, capital expenditures of $1.240 billion, and $0.607 billion in share repurchases | CRH Q2 2026 results announcement cash flow statement | July 30, 2026 |
| Arcosa acquisition | $8.5 billion enterprise value all-cash at $150 per share, announced June 22, 2026, expected to close in Q1 2027, with about $175 million of run-rate synergies by year three | CRH Arcosa acquisition announcement and Q2 2026 call | July 30, 2026 |
| Buyback pause | The latest buyback tranche completed July 28, 2026, bringing year-to-date repurchases to $0.7 billion; no new tranche has been initiated because of the Arcosa agreement | CRH Q2 2026 results announcement | July 30, 2026 |
| Dividend | Quarterly dividend of $0.39 per share up 5%, ex-dividend date August 14, 2026, annual yield near 1.64%, payout ratio near 21.5% | CRH Q2 2026 results announcement and StockAnalysis dividend page | August 2, 2026 |
| Valuation ratios | Trailing P/E 16.75, forward P/E 15.36, P/S 1.64, P/B 2.63, P/FCF 22.85, EV/EBITDA 10.21 | StockAnalysis CRH statistics | August 2, 2026 |
| Analyst consensus | Strong Buy from 21 to 22 analysts with an average target of $140.29, low of $105, median of $142.50, and high of $165 | StockAnalysis CRH forecast | July 31, 2026 |
| Recent analyst target moves | Stephens $135 to $125, Truist $130, Barclays $131, Wells Fargo $135 to $132, Citi $146 to $138, Jefferies $149 to $165.60 | StockAnalysis CRH forecast latest forecasts | July 31, 2026 |
| FY2026 and FY2027 consensus estimates | FY2026 revenue $39.69 billion with adjusted EPS $5.92, FY2027 revenue $42.06 billion with adjusted EPS $6.69 | StockAnalysis CRH forecast financial forecast | July 31, 2026 |
| Technical snapshot | 5-day MA $99.40, 20-day MA $101.98, 50-day MA $104.88, 100-day MA $107.23, 200-day MA $113.98, 14-day RSI near 34.40 | StockAnalysis CRH statistics and Barchart technical analysis | July 31, 2026 |
| Short interest | 13.95 million shares short, 2.37% of shares outstanding, about 2.97 days to cover | StockAnalysis CRH statistics | August 2, 2026 |
| 52-week range | $93.58 to $131.55, with price down about 23.87% year to date | StockAnalysis CRH statistics | August 2, 2026 |
This CRH AI stock analysis is an informational research tool only and is not investment advice, a recommendation, or a promise of future returns. Forecast ranges are scenarios based on available public data as of August 2, 2026 and can be wrong if the Arcosa transaction, fundamentals, market prices, interest rates, construction demand, or investor sentiment change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
